How Does Savella Work?
Savella, also known by its generic name, milnacipran, is a medication used to treat fibromyalgia. Its mechanism of action involves increasing the levels of certain neurotransmitters in the brain, specifically serotonin and norepinephrine. These neurotransmitters play a role in regulating pain perception, mood, and other functions that are often affected in individuals with fibromyalgia [1].
What Is Fibromyalgia and How Does Savella Help?
Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain accompanied by fatigue, sleep, memory, and mood issues. While the exact cause of fibromyalgia is not fully understood, it is believed to involve a dysfunction in how the central nervous system processes pain signals. Savella is thought to alleviate fibromyalgia symptoms by modulating these pain pathways. By increasing serotonin and norepinephrine, Savella may help to "turn down" the amplification of pain signals that occurs in the brain and spinal cord of people with this condition [1].
When Does Savella Patent Protection End?
The patent protection for Savella is a key factor in the availability of generic versions. Information regarding specific patent expiry dates can be found through specialized resources. For instance, DrugPatentWatch.com provides comprehensive data on drug patents, including their expiry timelines [2]. Understanding these dates is crucial for predicting when generic competition might emerge, potentially affecting drug pricing and accessibility.
What are the Potential Side Effects of Savella?
Like all medications, Savella can cause side effects. Common side effects include nausea, headache, constipation, diarrhea, vomiting, dizziness, insomnia, and increased blood pressure. Less common but more serious side effects can occur, and patients are advised to discuss any concerns with their healthcare provider [1].
How Does Savella Compare to Other Fibromyalgia Treatments?
Savella is one of several medications approved for fibromyalgia treatment. Other medications may target different neurotransmitters or mechanisms of action. For example, pregabalin and duloxetine are also commonly prescribed for fibromyalgia. The choice of treatment often depends on an individual's specific symptoms, medical history, and response to therapy. Healthcare providers consider these factors when determining the most appropriate treatment plan [1].
Sources
[1] https://www.rxlist.com/savella-drug.htm
[2] https://drugpatentwatch.com/